HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)

South Korea · Delayed Price · Currency is KRW

9,950.00

+60.00 (0.61%)

Oct 28, 2026, 3:30 PM KST

HLB Pharmaceutical Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2019	FY 2018	FY 2017
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Revenue	251,946	205,582	137,082	36,100	20,541	15,558
Revenue Growth	68.61%	49.97%	279.73%	75.75%	32.03%	-
Gross Profit	116,163	106,416	86,526	18,042	4,465	2,760
Operating Income	1,870	1,064	1,474	1,441	-5,826	-3,853
Net Income	2,757	4,572	2,020	472.66	-7,060	-5,447
Earnings Per Share	83.14	140.00	63.00	34.13	-521.49	-455.00
EPS Growth	-52.07%	122.22%	84.58%	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2019	FY 2018	FY 2017
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Cash & Investments	19,184	22,137	21,992	15,163	9,107	11,389
Total Debt	19,990	20,684	16,055	13,198	7,694	14,953
Net Cash (Debt)	-806.13	1,453	5,938	1,965	1,413	-3,564
Net Cash Growth	-	-75.53%	202.18%	39.05%	-	-
Net Cash Per Share	-24.43	44.45	185.74	141.88	104.39	-297.72

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2019	FY 2018	FY 2017
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Operating Cash Flow	4,328	568.98	6,841	1,353	-1,777	-784.3
Capital Expenditures	-8,617	-7,210	-2,799	-1,397	-1,095	-2,236
Free Cash Flow	-4,290	-6,642	4,042	-43.8	-2,872	-3,020
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2019	FY 2018	FY 2017
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Gross Margin	46.11%	51.76%	63.12%	49.98%	21.74%	17.74%
Operating Margin	0.74%	0.52%	1.07%	3.99%	-28.37%	-24.77%
Pretax Margin	1.19%	2.43%	0.85%	-0.34%	-27.84%	-35.76%
Profit Margin	1.09%	2.22%	1.47%	1.31%	-34.37%	-35.01%
FCF Margin	-1.70%	-3.23%	2.95%	-0.12%	-13.98%	-19.41%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2019	FY 2018	FY 2017
Period Ending	Oct '26 Oct 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
PE Ratio	119.68	49.27	167.55	159.09	-	-
P/FCF Ratio	-	-	83.73	-	-	-
PS Ratio	1.29	1.10	2.47	2.08	2.85	5.16